46 related articles for article (PubMed ID: 9932729)
21. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
22. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
23. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
24. Therapy for acute pancreatitis with platelet-activating factor receptor antagonists.
Chen C; Xia SH; Chen H; Li XH
World J Gastroenterol; 2008 Aug; 14(30):4735-8. PubMed ID: 18720532
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.
Feuerstein G; Rabinovici R; Leor J; Winkler JD; Vonhof S
J Lipid Mediat Cell Signal; 1997 Mar; 15(3):255-84. PubMed ID: 9041476
[TBL] [Abstract][Full Text] [Related]
26. Development of GPIIb/IIIa antagonists as antithrombotic drugs.
Nichols AJ; Ruffolo RR; Huffman WF; Poste G; Samanen J
Trends Pharmacol Sci; 1992 Nov; 13(11):413-7. PubMed ID: 1440877
[TBL] [Abstract][Full Text] [Related]
27. [Research progress of platelet activating factor(PAF) receptor antagonist].
Li XQ; Geng T; Huang WZ; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(7):1392-1403. PubMed ID: 29728028
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in ginkgolide research.
Braquet P; Esanu A; Buisine E; Hosford D; Broquet C; Koltai M
Med Res Rev; 1991 May; 11(3):295-355. PubMed ID: 1647474
[No Abstract] [Full Text] [Related]
29. The potential pathophysiological role of platelet-activating factor in human diseases.
Kroegel C
Klin Wochenschr; 1988 May; 66(9):373-8. PubMed ID: 2839728
[TBL] [Abstract][Full Text] [Related]
30. Peptides derived from platelet non-integrin collagen-receptors or types I and III collagen inhibit collagen-platelet interaction.
Chiang TM; Zhu J; Woo-Rasberry V
Cardiovasc Hematol Disord Drug Targets; 2007 Mar; 7(1):71-5. PubMed ID: 17346130
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Recent Pat Inflamm Allergy Drug Discov; 2008 Jan; 2(1):72-6. PubMed ID: 19075994
[TBL] [Abstract][Full Text] [Related]
32. Platelet aggregation and exogenous factors from animal sources.
Kini RM
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):301-25. PubMed ID: 15578956
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants.
Tibiriçá E
Cardiovasc Drug Rev; 2001; 19(4):313-28. PubMed ID: 11830750
[TBL] [Abstract][Full Text] [Related]
34. Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective.
Hsueh W; Caplan MS; Tan X; MacKendrick W; Gonzalez-Crussi F
Pediatr Dev Pathol; 1998; 1(1):2-16. PubMed ID: 10463267
[No Abstract] [Full Text] [Related]
35. Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients.
Harishkumar R; Hans S; Stanton JE; Grabrucker AM; Lordan R; Zabetakis I
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297097
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor antagonists.
Koltai M; Braquet PG
Clin Rev Allergy; 1994; 12(4):361-80. PubMed ID: 7743462
[No Abstract] [Full Text] [Related]
37. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.
Nassif A; Longo WE; Mazuski JE; Vernava AM; Kaminski DL
Dis Colon Rectum; 1996 Feb; 39(2):217-23. PubMed ID: 8620791
[TBL] [Abstract][Full Text] [Related]
38. Platelet aggregation and platelet-inhibiting drugs.
Nenci GG
Neurochem Pathol; 1987 Aug; 7(1):23-32. PubMed ID: 3328834
[TBL] [Abstract][Full Text] [Related]
39. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches.
Gauer JS; Ajjan RA; Ariëns RAS
J Am Heart Assoc; 2022 Oct; 11(20):e027071. PubMed ID: 36250653
[TBL] [Abstract][Full Text] [Related]
40. Is there a case for PAF antagonists in the treatment of ischemic states?
Braquet P; Paubert-Braquet M; Koltai M; Bourgain R; Bussolino F; Hosford D
Trends Pharmacol Sci; 1989 Jan; 10(1):23-30. PubMed ID: 2688213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
